Evaluation of Production Lots of a Rapid Point-of-Care Lateral Flow Serological Test Intended for Identification of IgM and IgG against the N-Terminal Part of the Spike Protein (S1) of SARS-CoV-2

The potential of rapid point-of-care (POC) tests has been subject of doubt due to an eventual risk of production errors. The aim was therefore to evaluate the two separate production lots of a commercial POC lateral flow test, intended for the detection of IgM and IgG against the SARS-CoV-2 spike pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffman, Tove, Kolstad, Linda, Rönnberg, Bengt, Lundkvist, Åke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230246/
https://www.ncbi.nlm.nih.gov/pubmed/34072890
http://dx.doi.org/10.3390/v13061043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230246/
https://www.ncbi.nlm.nih.gov/pubmed/34072890
http://dx.doi.org/10.3390/v13061043

Ejemplares similares